Source: PRWeb

Press Release: Seraphina : Seraphina Therapeutics Co-Founder and CEO Is A 2025 CNBC Changemaker

Dr. Stephanie Venn-Watson is recognized among exceptional leaders breaking down barriers and inspiring the world SAN DIEGO, Feb. 25, 2025 /PRNewswire-PRWeb/ -- Dr. Stephanie Venn-Watson, Co-Founder and Co-CEO of Seraphina Therapeutics, has been named a 2025 CNBC Changemaker for her...

Read full article »
Seraphina's Competitors | Seraphina's News | Seraphina's Financials
Stay up-to-date with the latest news on Seraphina
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Eric Venn-Watson's photo - Co-Founder of Seraphina

Co-Founder

Eric Venn-Watson

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Seraphina